Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012 (2012), Article ID 356236, 3 pages
http://dx.doi.org/10.1155/2012/356236
Case Report

Diphencyprone Induced Vitiligo: A Case Report

1Skin and Stem cell Research Center, Tehran University of Medical Sciences, Tehran 19377957511, Iran
2Center for Research and Training in Skin Disease and Leprosy, Tehran University of Medical Sciences, Tehran 1416613675, Iran
3Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran 13145-258, Iran
4Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan 81876-98191, Iran

Received 30 December 2011; Accepted 15 March 2012

Academic Editor: Michail Varras

Copyright © 2012 Mohammad Ali Nilforoushzadeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Gilhar, R. Paus, and R. S. Kalish, “Lymphocytes, neuropeptides, and genes involved in alopecia areata,” Journal of Clinical Investigation, vol. 117, no. 8, pp. 2019–2027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. K. H. Safavi, S. A. Muller, V. J. Suman, A. N. Moshell, and L. J. Melton, “Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989,” Mayo Clinic Proceedings, vol. 70, no. 7, pp. 628–633, 1995. View at Google Scholar · View at Scopus
  3. G. Avgerinou, S. Gregoriou, D. Rigopoulos, A. Stratigos, D. Kalogeromitros, and A. Katsambas, “Alopecia areata: topical immunotherapy treatment with diphencyprone,” Journal of the European Academy of Dermatology and Venereology, vol. 22, no. 3, pp. 320–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Garg and A. G. Messenger, “Alopecia areata: evidence-based treatments,” Seminars in Cutaneous Medicine and Surgery, vol. 28, no. 1, pp. 15–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Ganzetti, O. Simonetti, A. Campanati, K. Giuliodori, and A. Offidani, “Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo,” Acta Dermato-Venereologica, vol. 90, no. 6, pp. 642–643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Shapiro and S. Madani, “Alopecia areata: diagnosis and management,” International Journal of Dermatology, vol. 38, no. 1, pp. 19–24, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Cotellessa, K. Peris, E. Caracciolo, C. Mordenti, and S. Chimenti, “The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata,” Journal of the American Academy of Dermatology, vol. 44, no. 1, pp. 73–76, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Hunter, O. Shaker, and N. Marei, “Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers,” Journal of Dermatological Treatment, vol. 22, no. 1, pp. 2–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Perret, L. Wiesner Menzel, and R. Happle, “Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata,” Acta Dermato-Venereologica, vol. 64, no. 1, pp. 26–30, 1984. View at Google Scholar · View at Scopus
  10. P. Duhra and I. S. Foulds, “Persistent vitiligo induced by diphencyprone,” British Journal of Dermatology, vol. 123, no. 3, pp. 415–416, 1990. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Henderson and A. Ilchyshyn, “Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis,” British Journal of Dermatology, vol. 133, no. 3, pp. 496–497, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Yadav, S. Dogra, and I. Kaur, “An unusual anatomical colocalization of alopecia areata and vitiligo in a child, and improvement during treatment with topical prostaglandin E2,” Clinical and Experimental Dermatology, vol. 34, no. 8, pp. e1010–e1011, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. B. B. Adams and A. W. Lucky, “Colocalization of alopecia areata and vitiligo,” Pediatric Dermatology, vol. 16, no. 5, pp. 364–366, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Dhar and A. J. Kanwar, “Colocalization of vitiligo and alopecia areata,” Pediatric Dermatology, vol. 11, no. 1, pp. 85–86, 1994. View at Google Scholar · View at Scopus
  15. P. Mario Cezar, “Vitiligo after diphencyprone for alopecia areata,” Dermatology Research and Practice, vol. 2010, Article ID 171265, 2 pages, 2010. View at Publisher · View at Google Scholar